GLAST is the predominant glutamate transporter in the cerebellum and contributes substantially to glutamate transport in forebrain. This astroglial glutamate transporter quickly binds and clears synaptically released glutamate and is principally responsible for ensuring that synaptic glutamate concentrations remain low. This process is associated with a significant energetic cost. Compartmentalization of GLAST with mitochondria and proteins involved in energy metabolism could provide energetic support for glutamate transport. Therefore, we performed immunoprecipitation and co-localization experiments to determine if GLAST might co-compartmentalize with proteins involved in energy metabolism. GLAST was immunoprecipitated from rat cerebellum and subunits of the Na+/K+ ATPase, glycolytic enzymes, and mitochondrial proteins were detected. GLAST co-localized with mitochondria in cerebellar tissue. GLAST also co-localized with mitochondria in fine processes of astrocytes in organotypic hippocampal slice cultures. From these data, we hypothesized that mitochondria participate in a macromolecular complex with GLAST to support oxidative metabolism of transported glutamate. To determine the functional metabolic role of this complex, we measured CO2 production from radiolabeled glutamate in cultured astrocytes and compared it to overall glutamate uptake. Within 15 min, 9% of transported glutamate was converted to CO2. This CO2 production was blocked by inhibitors of glutamate transport and glutamate dehydrogenase, but not by an inhibitor of glutamine synthetase. Our data support a model in which GLAST exists in a macromolecular complex that allows transported glutamate to be metabolized in mitochondria to support energy production. (C) 2012 Elsevier Ltd. All rights reserved.
The glutamate transporter, GLAST, participates in a macromolecular complex that supports glutamate metabolism
Creators
Deborah E. Bauer - University of Pennsylvania
Joshua G. Jackson - Children's Hospital of Philadelphia
Elizabeth N. Genda - Children's Hospital of Philadelphia
Misty M. Montoya - Children's Hospital of Philadelphia
Marc Yudkoff - Children's Hospital of Philadelphia
Michael B. Robinson - University of Pennsylvania
Publication Details
Neurochemistry international, v 61(4), pp 566-574
Publisher
Elsevier
Number of pages
9
Grant note
K12GM081259 / Institutional Research and Academic Career Development Award
T32NS007413 / Training Grant in Neurodevelopmental Disabilities
R25GM071745 / University of Pennsylvania Postbaccalaureate Research Education Program
P30HD026979 / EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
T32NS007413 / NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)
K12GM081259 / NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS)
P30HD26979 / Analytical Neurochemistry Core of the Institutional Intellectual and Developmental Disabilities Research Center
Resource Type
Journal article
Language
English
Academic Unit
Pharmacology and Physiology
Web of Science ID
WOS:000309623600016
Scopus ID
2-s2.0-84865735219
Other Identifier
991021900192304721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: